Equifax Inc. logo

Equifax Inc. (EFX)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
161. 25
-0.01
-0.0062%
$
18.95B Market Cap
57.83 P/E Ratio
2.24% Div Yield
2.35M Volume
6.64 Eps
$ 161.26
Previous Close
Add Transaction
Day Range
159.6 164.43
Year Range
137.01 238.94
Want to track EFX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Equifax: Near-Term Weakness That May Lead To Guidance Revision (Rating Downgrade)

Equifax: Near-Term Weakness That May Lead To Guidance Revision (Rating Downgrade)

I am downgrading Equifax stock to a hold rating due to weak FY25 guidance, soft mortgage inquiry outlook, and hiring market pressures. Despite solid 4Q24 results and medium-term growth potential, the near-term earnings outlook is poor with decelerating revenue and EPS growth. Elevated mortgage rates and declining hiring volumes are significant headwinds, limiting EFX's ability to sustain recent growth rates.

Seekingalpha | 1 year ago
Equifax Inc. (EFX) Q4 2024 Earnings Call Transcript

Equifax Inc. (EFX) Q4 2024 Earnings Call Transcript

Equifax Inc. (NYSE:EFX ) Q4 2024 Earnings Conference Call February 6, 2025 8:30 AM ET Company Participants Trevor Burns - Senior Vice President, Head of Corporate Investor Relations Mark Begor - Chief Executive Officer John Gamble - Chief Financial Officer Conference Call Participants Jeff Muller - Baird Manav Patnaik - Barclays Andrew Steinerman - JPMorgan Toni Kaplan - Morgan Stanley Faiza Alwy - Deutsche Bank Kyle Peterson - Needham Craig Huber - Huber Research Partners Jason Haas - Wells Fargo Owen Lau - Oppenheimer Andrew Nicholas - William Blair Kelsey Zhu - Autonomous Research Scott Wurtzel - Wolfe Research Matt O'Neill - FT Partners Simon Clinch - Redburn Atlantic Arthur Truslove - Citi George Tong - Goldman Sachs Operator Greetings and welcome to the Equifax Corporate's Fourth Quarter 2024 Earning Conference Call. This time, all participants are in a listen-only mode.

Seekingalpha | 1 year ago
Equifax Q4 Earnings Beat, Revenues Miss Despite Strong Segments

Equifax Q4 Earnings Beat, Revenues Miss Despite Strong Segments

Robust growth across segments drives EFX's top line in the fourth quarter of 2024.

Zacks | 1 year ago
Weaker Hiring Market Creates Revenue Headwinds for Equifax

Weaker Hiring Market Creates Revenue Headwinds for Equifax

For Equifax, macro headwinds from a job market slowdown and the volatile mortgage market — where uneven loan demand has been a hallmark amid relatively high interest rates — have impacted top-line momentum and forward-looking guidance. As discussed during an earnings call with analysts Thursday (Feb.

Pymnts | 1 year ago
Equifax (EFX) Reports Q4 Earnings: What Key Metrics Have to Say

Equifax (EFX) Reports Q4 Earnings: What Key Metrics Have to Say

The headline numbers for Equifax (EFX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 1 year ago
Equifax (EFX) Surpasses Q4 Earnings Estimates

Equifax (EFX) Surpasses Q4 Earnings Estimates

Equifax (EFX) came out with quarterly earnings of $2.12 per share, beating the Zacks Consensus Estimate of $2.10 per share. This compares to earnings of $1.81 per share a year ago.

Zacks | 1 year ago
Equifax Gears Up to Report Q4 Earnings: What's in the Offing?

Equifax Gears Up to Report Q4 Earnings: What's in the Offing?

EFX's fourth-quarter 2024 revenues are expected to have increased due to healthy mortgage activities.

Zacks | 1 year ago
Ahead of Equifax (EFX) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Ahead of Equifax (EFX) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Equifax (EFX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.

Zacks | 1 year ago
Equifax (EFX) Earnings Expected to Grow: Should You Buy?

Equifax (EFX) Earnings Expected to Grow: Should You Buy?

Equifax (EFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Akero: Reversal Of Cirrhosis With EFX Is A 'First' In F4 MASH Patients

Akero: Reversal Of Cirrhosis With EFX Is A 'First' In F4 MASH Patients

Company's stock surged over 100% after positive 96-week results from its phase 2b SYMMETRY study using EFX to treat F4 compensated cirrhosis due to MASH patients. The company achieved a significant reversal of cirrhosis, with 39% of patients showing improvement compared to 15% on placebo, highlighting EFX's efficacy. Upcoming catalysts include phase 3 SYNCHRONY studies targeting F1-F3 and F2-F3 MASH patients, with data expected in the first half of 2026 and 2027, respectively.

Seekingalpha | 1 year ago
Equifax to Settle CFPB Allegations That It Didn't Ensure Accuracy of Credit Reports

Equifax to Settle CFPB Allegations That It Didn't Ensure Accuracy of Credit Reports

Equifax has agreed to a settlement and consent order that will resolve Consumer Financial Protection Bureau (CFPB) allegations that the consumer reporting agency failed to take steps to ensure the accuracy of its credit reports.

Pymnts | 1 year ago
US consumer bureau fines Equifax $15 million for issues fixing consumer disputes

US consumer bureau fines Equifax $15 million for issues fixing consumer disputes

The U.S. Consumer Financial Protection Bureau announced on Friday it had fined credit reporting bureau Equifax $15 million for failing to sufficiently investigate consumer disputes of its credit reports.

Reuters | 1 year ago
Loading...
Load More